STOCK TITAN

BioMarin to Participate in Four Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) will participate in four virtual investor conferences, as announced on October 25, 2021. Live audio webcasts of the presentations will be accessible via the company's investor relations website. Archived recordings will also be available for a limited time post-conference. BioMarin focuses on developing therapies for rare genetic diseases, with a range of commercial and clinical product candidates. For more details, visit www.biomarin.com.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., Oct. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release.

Contacts:  


Investors                                                                    

Media

Traci McCarty                                                            

Debra Charlesworth

BioMarin Pharmaceutical Inc.                                      

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                               

(415) 455-7451

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-four-upcoming-virtual-investor-conferences-301407128.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What is the date of BioMarin's announcement about the investor conferences?

BioMarin announced its participation in the investor conferences on October 25, 2021.

How many virtual investor conferences is BioMarin participating in?

BioMarin is participating in four virtual investor conferences.

Where can I access the live webcasts for BioMarin's presentations?

Live webcasts for BioMarin's presentations can be accessed at their investor relations website.

Will there be archived versions of BioMarin's presentations available?

Yes, archived versions of BioMarin's presentations will be available for a limited time after the conferences.

What is BioMarin Pharmaceutical known for?

BioMarin Pharmaceutical is known for developing therapies for serious and life-threatening rare genetic diseases.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

12.70B
188.90M
0.87%
97.78%
2.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO